Kistenfeger Q, Haight PJ, Levine M, Wang H, et al. The impact of antibiotics, proton pump inhibitors, H2-receptor antagonists, and steroids on survival in ovarian cancer patients receiving PARP inhibitor therapy. Gynecol Oncol 2025;198:90-95.
PMID: 40450912